Answers are grounded in this paper and cite their sources.
Provides a clinical review of new oral anticoagulants, focusing on lab monitoring and bleeding management, particularly tailored for interventional radiologists.
New oral anticoagulants (NOAC) are the latest addition to anticoagulant armamentarium. Unlike traditional anti-coagulants like warfarin, lab monitoring and management of bleeding complications secondary to these agents is different. As more and more patients are being switched to these drugs, interventional radiologists in particular will benefit from a clinical review of NOAC.
No takes yet. Share an insight, caveat, or question.
Laroia et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: